Shibing Li
- Topics
- RNA modifications and cancer (4 papers)interferon and immune responses (2 papers)Cancer, Hypoxia, and Metabolism (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Shibing Li
14 papers receiving 349 citations
Peers
Comparison fields: 5 of 104
- Molecular Biology 152
- Pulmonary and Respiratory Medicine 80
- Cancer Research 76
- Immunology 58
- Oncology 54
Countries citing papers authored by Shibing Li
This map shows the geographic impact of Shibing Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shibing Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shibing Li more than expected).
Fields of papers citing papers by Shibing Li
This network shows the impact of papers produced by Shibing Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shibing Li. The network helps show where Shibing Li may publish in the future.
Co-authorship network of co-authors of Shibing Li
This figure shows the co-authorship network connecting the top 25 collaborators of Shibing Li. A scholar is included among the top collaborators of Shibing Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shibing Li. Shibing Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | Knockdown of LPCAT1 Repressed Hepatocellular Carcinoma Growth and Invasion by Targeting S100A11. | 3 |
| 6 | 15 | |
| 7 | 23 | |
| 8 | 6 | |
| 9 | 104 | |
| 10 | 32 | |
| 11 | 15 | |
| 12 | 16 | |
| 13 | 1 | |
| 14 | 28 | |
| 15 | 29 | |
| 16 | 2 | |
| 17 | 21 | |
| 18 | 59 |
About Shibing Li
Shibing Li is a scholar working on Cancer Research, Otorhinolaryngology and Pharmacy, having authored 18 papers that have together received 354 indexed citations. Recurring topics across this work include RNA modifications and cancer (4 papers), interferon and immune responses (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Cancer Research (76 citations), Management Science and Operations Research (46 citations) and Immunology (58 citations). Shibing Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Liang Liang, Yongjun Li, Tianliang Xia, Yuan Li, Lin‐Quan Tang, Xiaoyun Li, Shanshan Guo, Li‐Ting Liu, Hai‐Qiang Mai and Chaochao Du. Their work appears in journals such as Journal of Biological Chemistry, British Journal of Cancer and Cell Death and Differentiation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.